These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 23716114)
1. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma. Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325 [TBL] [Abstract][Full Text] [Related]
3. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349 [TBL] [Abstract][Full Text] [Related]
4. The clinical implication of SS18-SSX fusion gene in synovial sarcoma. Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel SSX1 fusions in synovial sarcoma. Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309 [TBL] [Abstract][Full Text] [Related]
6. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis. Jones KB; Barrott JJ; Xie M; Haldar M; Jin H; Zhu JF; Monument MJ; Mosbruger TL; Langer EM; Randall RL; Wilson RK; Cairns BR; Ding L; Capecchi MR Oncogene; 2016 Sep; 35(38):5021-32. PubMed ID: 26947017 [TBL] [Abstract][Full Text] [Related]
7. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of SS18-SSX1 expression by small interfering RNA inhibits growth and induces apoptosis in human synovial sarcoma cell line HS-SY-II in vitro. Peng C; Guo W; Yang Y; Zhao H Eur J Cancer Prev; 2008 Oct; 17(5):392-8. PubMed ID: 18714179 [TBL] [Abstract][Full Text] [Related]
9. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall. Kao YC; Sung YS; Zhang L; Kenan S; Singer S; Tap WD; Swanson D; Dickson BC; Antonescu CR Genes Chromosomes Cancer; 2017 Apr; 56(4):296-302. PubMed ID: 27914109 [TBL] [Abstract][Full Text] [Related]
10. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma. Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645 [TBL] [Abstract][Full Text] [Related]
11. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma. Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315 [TBL] [Abstract][Full Text] [Related]
12. The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Banito A; Li X; Laporte AN; Roe JS; Sanchez-Vega F; Huang CH; Dancsok AR; Hatzi K; Chen CC; Tschaharganeh DF; Chandwani R; Tasdemir N; Jones KB; Capecchi MR; Vakoc CR; Schultz N; Ladanyi M; Nielsen TO; Lowe SW Cancer Cell; 2018 Mar; 33(3):527-541.e8. PubMed ID: 29502955 [TBL] [Abstract][Full Text] [Related]
13. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein. Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893 [TBL] [Abstract][Full Text] [Related]
15. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816 [TBL] [Abstract][Full Text] [Related]
16. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens. Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153 [TBL] [Abstract][Full Text] [Related]
17. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Kadoch C; Crabtree GR Cell; 2013 Mar; 153(1):71-85. PubMed ID: 23540691 [TBL] [Abstract][Full Text] [Related]
18. Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases. Przybyl J; Sciot R; Rutkowski P; Siedlecki JA; Vanspauwen V; Samson I; Debiec-Rychter M Tumour Biol; 2012 Dec; 33(6):2245-53. PubMed ID: 22976541 [TBL] [Abstract][Full Text] [Related]
19. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity. Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599 [TBL] [Abstract][Full Text] [Related]
20. Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Su L; Sampaio AV; Jones KB; Pacheco M; Goytain A; Lin S; Poulin N; Yi L; Rossi FM; Kast J; Capecchi MR; Underhill TM; Nielsen TO Cancer Cell; 2012 Mar; 21(3):333-47. PubMed ID: 22439931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]